SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-23-077648
Filing Date
2023-07-03
Accepted
2023-07-03 16:44:47
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-1/A tm2313083d10_s1a.htm S-1/A 102750
2 EXHIBIT 1.1 tm2313083d10_ex1-1.htm EX-1.1 334095
3 EXHIBIT 2.1 tm2313083d10_ex2-1.htm EX-2.1 71054
4 EXHIBIT 3.4 tm2313083d10_ex3-4.htm EX-3.4 52743
5 EXHIBIT 3.5 tm2313083d10_ex3-5.htm EX-3.5 159534
6 EXHIBIT 4.1 tm2313083d10_ex4-1.htm EX-4.1 5784
7 EXHIBIT 4.2 tm2313083d10_ex4-2.htm EX-4.2 136691
8 EXHIBIT 10.1 tm2313083d10_ex10-1.htm EX-10.1 59209
9 EXHIBIT 10.14 tm2313083d10_ex10-14.htm EX-10.14 133968
10 EXHIBIT 10.15 tm2313083d10_ex10-15.htm EX-10.15 106600
11 EX-FILING FEES tm2313083d10_ex-filingfees.htm EX-FILING FEES 12174
12 GRAPHIC tm2313083d10_ex4-1img001.jpg GRAPHIC 306962
13 GRAPHIC tm2313083d10_ex4-1img002.jpg GRAPHIC 122919
  Complete submission text file 0001104659-23-077648.txt   1767993
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-272831 | Film No.: 231065686
SIC: 2836 Biological Products, (No Diagnostic Substances)